Late cancer detection leads to death. Today, 50% of cancer diagnoses are late, meaning that most of these people die within 5 years. Oncoliq’s mission is to reduce cancer-caused deaths globally through an early detection approach. Their solution is a blood test that detects up to 50 cancer types. They combine molecular biology strategies based on PCR with machine learning, to develop algorithms that indicate whether a person has a tumor in a specific organ. Oncoliq’s technology is highly sensitive, non-toxic, non-invasive and low cost.
Login or Register
You need to be logged in to use this feature.
Argentina
Oncoliq
Content by this speaker
Explore more content of Falling Walls
Events with Oncoliq
Falling Walls Venture Pitches – Session 3: Health Solutions
Further Activities to have a look at